SUNNYVALE, Calif.--(BUSINESS WIRE)--Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it will showcase long-term imaging results of its CE Mark-approved DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold Systems at EuroPCR in Paris. EuroPCR is the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions.
Help employers find you! Check out all the jobs and post your resume.
